| | |
| Debt-wracked nations could learn from Norway, prime minister says Wednesday, Sep 25, 2013 08:43 PM PDT | Top |
| Joint U.S.-Russian crew reaches space station Wednesday, Sep 25, 2013 08:21 PM PDT | Top |
| Termites' powerful weapon against extermination? Their own poop Wednesday, Sep 25, 2013 05:32 PM PDT By Barbara Liston ORLANDO (Reuters) - Scientists trying to understand why destructive wood-eating termites are so resistant to efforts to exterminate them have come up with an unusually repugnant explanation. Termites' practice of building nests out of their own feces creates a scatological force field that Florida scientists now believe is the reason biological controls have failed to stop their pestilential march all over the world. ... Full Story | Top |
| Pentagon aims to finalize Lockheed F-35 contract within days Wednesday, Sep 25, 2013 03:46 PM PDT | Top |
| Prominent Mexicans urge government to decriminalize marijuana Wednesday, Sep 25, 2013 03:14 PM PDT | Top |
| Joint Russian-U.S. crew blasts off for space station Wednesday, Sep 25, 2013 02:50 PM PDT | Top |
| BlackBerry, telecoms drag TSX lower Wednesday, Sep 25, 2013 02:34 PM PDT | Top |
| Six killed in Sudan clashes after fuel subsidies cut Wednesday, Sep 25, 2013 02:07 PM PDT | Top |
| Iran wants 'jump-start' in nuclear talks with big powers Wednesday, Sep 25, 2013 02:00 PM PDT | Top |
| Price cap plan wipes more than 1 billion pounds off UK energy firms Wednesday, Sep 25, 2013 10:30 AM PDT | Top |
| FDA strengthens hepatitis B warning on 2 cancer drugs Wednesday, Sep 25, 2013 09:33 AM PDT WASHINGTON (Reuters) - U.S. health regulators have strengthened the warnings on two blood cancer drugs to reflect the risk that they may reactivate the hepatitis B virus in patients previously infected with the disease. The warnings affect GlaxoSmithKline Plc's Arzerra, which was approved in the United States in 2009 to treat chronic lymphocytic leukemia (CLL); and Rituxan, a drug made by Roche Holding AG and Biogen Idec Inc that is approved to treat a variety of conditions including CLL, non-Hodgkin's Lymphoma and rheumatoid arthritis. The U.S. ... Full Story | Top |
| Ohio uses last lethal drug dose to execute convicted murderer Wednesday, Sep 25, 2013 09:24 AM PDT By Kim Palmer CLEVELAND (Reuters) - Ohio used the state's last available dose of the drug pentobarbital on Wednesday to execute a man described by prosecutors as a racist, who was convicted of killing a neighbor and then a police officer responding to the shooting. Harry Mitts Jr., 61, was pronounced dead at 10:30 a.m. ET (1430 GMT) at the Southern Ohio Correctional facility, a state corrections department official said. Mitts, who was white, was convicted in 1994 of killing a neighbor, John Bryant, and then shooting to death Ohio police officer Dennis Glivar as he responded to the shooting. ... Full Story | Top |
| Factbox: German coalition watch Wednesday, Sep 25, 2013 09:21 AM PDT Chancellor Angela Merkel led her conservatives to their best result in decades in a German election on September 22, but must still find a coalition partner to secure a third term. She is expected to turn first to the center-left Social Democrats (SPD), with whom she ruled between 2005 and 2009, but could also talk with the environmentalist Greens. Below are key coalition-related quotes from senior officials since the election, as well as areas of potential compromise on policy and personnel. ... Full Story | Top |
| Sanofi cholesterol drug touted as potential $3 billion blockbuster Wednesday, Sep 25, 2013 08:53 AM PDT By Natalie Huet PARIS (Reuters) - A new cholesterol-lowering drug from Sanofi and Regeneron has the potential to become a $3-billion-dollar-plus blockbuster, according to analysts awaiting imminent late-stage trial results. The drug, dubbed alirocumab, is part of a group of biotech medicines known as PCSK9 inhibitors that offer a new way of fighting the build-up of artery-clogging fatty deposits that put millions of patients worldwide at risk of heart attacks. ... Full Story | Top |
| CFO resigns as Seanergy struggles to repay debt Wednesday, Sep 25, 2013 07:49 AM PDT (Reuters) - Seanergy Maritime Holdings Corp said chief financial officer resigned and the dry bulk shipper repeated concerns about its ability to stay in business after posting another quarter of losses. Shares of Seanergy, which sold three ships in July, were down 12 percent at $1.87 in morning trade on the Nasdaq. The troubles at Athens-based Seanergy underscore the sector-wide slump in rates, which has forced several shippers to restructure or seek bankruptcy protection in the past two years. CFO Christina Anagnostara will step down on November 1 but will remain on the board. ... Full Story | Top |
|

No comments:
Post a Comment